ReviewAutoimmunity reviews2017
IgG4-related disease: Evidence from six recent cohorts.
Review in Autoimmunity reviews, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- IgG4-Related Kidney Disease and IgG4-Related Retroperitoneal Fibrosis: An Update on Diagnosis and Treatment.Kidney international reports · 2026Review
- Immunoglobulin G4-Related Disease-Like Gastric Lesion Presenting as Submucosal Tumor-Like Lesions.DEN open · 2026Article
- New Developments in the Treatment of IgG4-Related Disease: A Comprehensive Clinical Approach.Journal of clinical medicine · 2025Review
- IgG4-Related Disease Inflamatory Pseudotumor Affecting the Sternoclavicular Joint: A Clinical Challenge.Case reports in immunology · 2025Article
- Pulmonary Manifestations of Primary Humoral Deficiencies.Canadian respiratory journal · 2022Review
- Response to Treatment in IgG4-Related Disease Assessed by Quantitative PET/CT Scan.Clinical nuclear medicine · 2021Article
- Performance of the 2019 ACR/EULAR classification criteria for IgG4-related disease and clinical phenotypes in a Spanish multicentre registry (REERIGG4).Rheumatology (Oxford, England) · 2021Article
- Giant IgG4-Related Pseudotumor of the Esophagus Resected with Endoscopic Submucosal Dissection: A Case Report and Review of the Literature.Turk patoloji dergisi · 2021Review
- Immunoglobulin G4-Related Disease Accompanied by Primary Myelofibrosis: Case Report.Frontiers in medicine · 2021Article
- Immunoglobulin G4-related Disease: Presentation of the First Case with Isolated Pterygopalatine Fossa Involvement.Cureus · 2019Article
- IgG4-related disease in a patient with HIV infection.BMJ case reports · 2019Article
- Temporal bone involvement of IgG4-related disease: a rare condition misleading to petrous apicitis causing lateral rectus palsy.BMJ case reports · 2019Article
- Retrospective single-centre analysis of IgG4-related disease patient population and treatment outcomes between 2007 and 2017.Rheumatology advances in practice · 2019Article
- Treatment and outcomes in patients with IgG4-related disease using the IgG4 responder index.Joint bone spine · 2018Article
- Autoimmunity in 2017.Clinical reviews in allergy & immunology · 2018Review
- IgG4-related disease: association between chronic rhino-sinusitis and systemic symptoms.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018Article
- The Clinicopathologic Spectrum of IgG4-Related DiseaseBalkan medical journal · 2018Article
- The Immunologic Paradoxes of IgG4-Related Disease.Clinical reviews in allergy & immunology · 2018Review
- Frequency and distribution of CD4+CXCR5+ follicular B helper T cells within involved tissues in IgG4‑related ophthalmic disease.Molecular medicine reports · 2017Article
- IgG4-related disease involving polyserous effusions with elevated serum interleukin-6 levels: a case report and literature review.Immunologic research · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
IgG4-related disease (IgG4-RD) is a rare autoimmune fibrosing disorder. In this review we aim to describe and compare the characteristics of the six largest IgG4-RD cohorts, since the new 2012 consensus diagnostic criteria were released. These observational studies were published between 2012 and 2015. Patients were included using the comprehensive diagnostic criteria or the 2012 consensus criteria. Results were reviewed and summarized. Most patients were middle aged men. Fibro-inflammatory masses developed in virtually all organs except the brain, with an unexplained preference for salivary glands, lymph nodes and pancreas. Corticosteroids were the treatment of choice but up to 40% of patients relapsed within the first year. Standardized response assessment tools, biomarkers and the validation of new treatments are still in development. In conclusion, the features of IgG4-RD are similar across the globe. At the moment, corticosteroids are the only validated treatment but rituximab seems to be promising.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.